Fig. 1From: Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomicsResistance rates of A. baumannii to antimicrobials. No resistance was detected in colistin or polymyxin B. The resistance of tigecycline is determined according to FDA interpretation criteria for Enterobacteriaceae. There is no breakpoint for aztreonam and sulbactamBack to article page